Application of parabacteroides dielsii in preparation of pharmaceutical preparation for treating Alzheimer's disease
A technology for Alzheimer's disease and pharmaceutical preparations, which is applied in the application field of Parabacteroides dischei in the preparation of Alzheimer's disease pharmaceutical preparations to achieve the effects of improving cognitive function and improving clinical symptoms
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] What the present embodiment takes is the administration mode that the live bacteria suspension of Parabacteroides distirii is taken orally (gavage), according to 1×10 9 The concentration of cfu / ml is 200ul / day for each mouse, orally administered once a day for 30 days. More convenient and safe oral preparations can be further developed in the future.
[0025] For AD model APP / PS1 mice (AD model mice are Thy1-APPsw / PSL166P transgenic mice (129S strain), referred to as APP / PS1 mice, from the Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the small Mice were introduced from the Rebecca Radde laboratory in Germany. Transgenic mice were modeled: Thy1-APPKM670 / 671NL and Thy1-PS1L166P were co-injected into C57BL6J oocyte male prokaryotic cells, and the resulting male mice were further compared with C57BL / 6J mice Mating. (Radde et al.2006)), intragastric administration of Parabacteroides distirii can significantly reduce...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


